I-ASV in Cardiac Surgery
ConditionVentilator Lung
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-120
SponsorMedical University of Vienna
About this trial
'POStoperative INTELLiVENT-adaptive support VEntilation in cardiac surgery patients II (POSITiVE II) is an investigator-initiated, international, multicenter, parallel, randomized clinical trial in patients after cardiac surgery.
Eligibility criteria
Qualifiers
1. aged > 18 years of age;
2. scheduled for elective cardiac surgery; and
3. expected to receive postoperative ventilation in the ICU for > 2 hours.
Disqualifiers
any emergency or semi-elective surgery (precluding informed written consent);
any surgery other than CABG, valve replacement or repair, or a combination (i.e., patients planned for surgery for congenital heart disease, or scheduled for heart transplantation are excluded);
enrolled in another interventional trail;
no written informed consent obtained;
Trial design
Treatments tested in this trial
- INTELLiVENT-ASV.
Treatment groups
328 Participants
are divided into 2 treatment groupsSponsors and collaborators
Medical University of Vienna
Lead sponsor
University Hospital Dubrava
Collaborator
Università degli Studi dell'Insubria
Collaborator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborator
University of Zurich
Collaborator
Source ClinicalTrials.gov